Table 2.
T0 and T1 PDEQ, PCL5 and HADS for anxiety and depression results (results stratified by age, gender and ICU hospitalization are available in Table 5).
| T0 (N = 109) | T1 (N = 64) | |
|---|---|---|
| PDEQ | ||
| PDEQ score (median, IQR) | 13 (11–23) | NA |
| Positive PDEQ (N, %)) | 49 (45.0%) | NA |
| PCL5 | ||
| PCL5 (median, IQR) | 11 (3–23) | 6 (3–16) |
| Positive PCL5 (N, %) | 15 (14.6%) | 7 (10.6%) |
| ≥1 symptom on PCL5 (N, %) | 88 (85.4%) | 58 (87.9%) |
| HADS-Anxiety | ||
| HADS-A (median, IQR) | 6 (3,5–9) | 4 (2,5–7,5) |
| Positive HADS-A (N,%) | 17 (15.7) | 6 (10.0) |
| HADS-depression | ||
| HADS-D (median, IQR) | 3 (1–8) | 2 (1–6) |
| Positive HADS-dep (N, %) | 20 (18.5) | 6 (10.0) |